Birkenstock Raises FY26 Revenue Forecast on Robust Full-Price Demand

What happened

Birkenstock raised its FY2026 sales growth forecast, citing resilient full-price demand from affluent shoppers for its premium sandals. This announcement comes after the company's December 2025 annual report highlighted double-digit growth and 31.8% adjusted EBITDA margins, but also flagged new U.S. tariffs, FX headwinds, and material weaknesses in internal controls. The raised forecast suggests that Birkenstock is successfully passing through costs and maintaining pricing power, which supports the brand's moat. However, the stock still trades at approximately 24x trailing earnings and around 17x EV/EBITDA, leaving little room for execution missteps or margin compression from tariffs and unfavorable euro-dollar rates. Overall, the news is a positive sign for demand, but it does not resolve the valuation overhang and governance concerns that underpinned the prior WAIT recommendation.

Implication

The raised revenue forecast confirms that Birkenstock's brand strength and full-price selling are holding up despite macro headwinds, which is a positive for top-line growth and margin stability. However, the repricing of tariffs and FX pressures could still squeeze profitability, and the company's heavy reliance on EU-based production for U.S. sales exposes it to trade policy shifts. Persistent material weaknesses in internal controls and a complex balance sheet with TRA obligations add governance and financial risk that are not reflected in the current premium multiple. At nearly 24x earnings and a substantial premium to conservative DCF estimates, the market already prices in continued double-digit growth and flawless execution, leaving limited upside. Investors should wait for either a meaningful pullback in valuation or clear evidence of tariff mitigation and control remediation before considering a more constructive stance.

Thesis delta

The prior WAIT stance remains unchanged. The raised revenue forecast indicates resilient demand and pricing power, slightly reducing top-line risk, but it does not address the valuation discount to intrinsic value or the tariff and governance concerns. We maintain a cautious view pending clearer execution on margin protection and control improvements.